Previous Article | Next Article 
Journal of Virology, May 2000, p. 4474-4482, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
An Evolutionarily Conserved Positively Charged Amino Acid in
the Putative Membrane-Spanning Domain of the Foamy Virus
Envelope Protein Controls Fusion Activity
Thomas
Pietschmann,1
Hanswalter
Zentgraf,2
Axel
Rethwilm,1,3 and
Dirk
Lindemann1,*
Institut für Virologie und
Immunbiologie, Universität Würzburg,
Würzburg,1 Angewandte
Tumorvirologie, Deutsches Krebsforschungszentrum,
Heidelberg,2 and Institut für
Virologie, Medizinische Fakultät Carl Gustav Carus,
Technische Universität Dresden, Dresden,3
Germany
Received 16 September 1999/Accepted 17 February 2000
 |
ABSTRACT |
Foamy viruses (FVs) are highly fusogenic, and their replication
induces massive syncytium formation in infected cell cultures which is
believed to be mediated by expression of the envelope (Env) protein.
The FV Env is essential for virus particle egress. The unusually long
putative membrane-spanning domain (MSD) of the transmembrane subunit
carries dispersed charged amino acids and has an important function for
particle envelopment. To better understand the capsid-envelope
interaction and Env-mediated cell fusion, we generated a variety of FV
MSD mutations. C-terminal deletions revealed the cytoplasmic domain to
be dispensable but the full-length MSD to be required for fusogenic
activity. The N-terminal 15 amino acids of the MSD were found to be
sufficient for membrane anchorage and promotion of FV particle release.
Expression of wild-type Env protein rarely induced syncytia due to
intracellular retention. Coexpression with FV Gag-Pol resulted in
particle export and a dramatic increase in fusion activity. A
nonconservative mutation of K959 in the middle of the
putative MSD resulted in increased fusogenic activity of Env in the
absence of Gag-Pol due to enhanced cell surface expression as well as
structural changes in the mutant proteins. Coexpression with Gag-Pol
resulted in a further increase in the fusion activity of mutant FV Env proteins. Our results suggest that an interaction between the viral
capsid and Env is required for FV-induced giant-cell formation and that
the positive charge in the MSD is an important determinant controlling
intracellular transport and fusogenic activity of the FV Env protein.
 |
INTRODUCTION |
Glycoproteins of enveloped viruses
mediate binding to the host cell and delivery of capsids to the
cytoplasm by fusing virion and cellular lipid membranes. For
retroviruses, binding to the cellular receptor is mediated by the
surface (SU) subunit of the Env protein, whereas the fusion of the
lipid membranes involves mainly the transmembrane (TM) subunit. The
latter mechanism has been best studied for the influenza virus
hemagglutinin (HA) protein (3, 4, 5). Recent studies on
retroviral Env proteins suggest some homology to HA at both the
structural and the functional level (20, 34). For the human
(HIV) and simian immunodeficiency viruses, murine leukemia virus
(MuLV), and Mason-Pfizer monkey virus (MPMV), the fusion activity of
Env proteins was found to be regulated by the cytoplasmic domain (CyD)
(2, 24, 28, 29). In the cases of MuLV and MPMV, the Env CyD
contains a C-terminal inhibitory domain that is cleaved during or
shortly after budding by the viral proteinase, thereby transferring the
Env protein into a fusogenic conformation (2, 28). For HIV
Env, which contains an extraordinarily long CyD, cleavage of the CyD is
not observed. However, the C-terminal portion of the CyD also controls the fusion activity, as artificial CyD truncations rendered the shortened mutants highly fusogenic (24, 29). Furthermore, it
has been demonstrated that the membrane-spanning domains (MSDs) of
these retroviral Env proteins are critical for the fusion process, as
mutations of the MSD affected fusion activity (18, 25, 27).
Foamy viruses (FVs) make up a separate group in the class of
Retroviridae. As indicated by their name, FVs are highly
fusogenic upon replication in most cell cultures. The replication
strategy of FVs shows several unique features not found for any other
retrovirus and bears some resemblance to that of the
Hepadnaviridae (for a review, see reference
23). A specialty with respect to their Env protein
is the strict requirement for coexpression of Env and Gag for the
budding and viral particle release process (1, 9, 32). Two
alternatively spliced forms of the FV Env protein are detected;
however, at least in vitro, only the gp130 form is required for viral
replication (12, 22). This form of the FV Env protein
contains an endoplasmic reticulum (ER) retrieval signal at the C
terminus of the CyD (15). Inactivation of this signal leads
to increased syncytium formation, most probably as a result of
increased Env transport to the cell surface (14). However,
we and others have shown that the ER retrieval signal and the CyD of
Env are dispensable for infectivity and in vitro replication (13,
26). Furthermore, we found previously that the putative MSD of
the FV TM subunit plays an important role for virus particle egress and
cannot be replaced by alternative forms of membrane anchorage or
heterologous domains of other retroviral Env proteins (26).
In the present study, we analyzed the role of the putative MSD and CyD
in regulation of FV Env protein fusion activity and dissected the
function of the MSD for particle release in further detail.
 |
MATERIALS AND METHODS |
Expression constructs.
The eukaryotic expression constructs
for various FV envelope mutants depicted in Fig.
1 are based on the previously described pcHFE-wt plasmid (EM02 mutation), which expresses only gp130 due to
inactivation of the internal splice donor and splice acceptor pair
within the FV Env coding region (22, 26). All point
mutations within the MSD (pcHFVenv EM21 through EM30, as described
below) were generated by recombinant PCR techniques (19)
using primers introducing the respective codon changes. The PCR
products were cloned into the pcHFE-wt plasmid as
NheI-EcoRI fragments, and the inserts were
completely sequenced to verify the desired sequence and to exclude
further mutations. In the mutant envelope proteins, the conserved,
positively charged lysine residue at position 959 of the amino acid
sequence was replaced conservatively (EM27, arginine), replaced with a
hydrophobic residue (EM21 and EM30, alanine and leucine, respectively),
or replaced with a negatively charged amino acid (EM28 and EM29,
glutamic acid and aspartic acid, respectively). A mutation of the
conserved proline at position 960 to alanine was introduced (EM22), or
a double mutation of the lysine-proline motif to two alanines was
created (EM23). Additionally, a deletion mutant was designed that is
truncated at amino acid 960 (EM31). This deletion mutant was generated
by inserting an NheI-EcoRI PCR insert with a
premature stop codon into pcHFE-wt. Furthermore, several previously
described deletion mutants were included in this study: pcHFE-1,
truncated at residue 981; pcHFE-2, truncated at amino acid 975; and
pcHFE-3Pi, which contains the FV Env ectodomain fused to the
phosphoglycolipid (GPI) anchor signal sequence derived from the human
placental alkaline phosphatase protein (26).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic illustration of the FV MSD and artificial
amino acid changes. (A) Organization of the FV genome and enlarged
C-terminal region of the Env protein containing the putative MSD and
CyD. LTR, long terminal repeat; IP, internal promoter. The dots below
the sequence indicate conserved amino acids in all known FV isolates. A
hydrophilicity plot of this region of the FV Env protein according to
Kyte-Doolittle generated by the Protean program (DNASTAR software) is
shown below. (B) Amino acid sequence of the individual FV mutants
described in this study. The designations indicate whether the mutants
are based on the wild-type sequence (+) or the mutant EM20
(R571T), in which the SU/TM cleavage site is inactivated
( ). Dashes represent amino acids that are identical to those in the
wild-type sequence (EM02).
|
|
In order to study Env functions independently of fusion activity, we
created several mutants in which SU-TM cleavage was abolished.
In EM20,
R
571 was altered to T
571, a mutation found
previously
to inactivate SU-TM cleavage in HIV-1 Env (
11).
The mutant PCR
product was inserted into the
StuI and
BsrGI restriction sites
of plasmid pcHFE-wt. Constructs EM33
through EM40 were created
by cloning
NheI-
EcoRI
fragments from the MSD mutants EM21 through
EM31 into the EM20
construct, which hence harbors both the SU-TM
cleavage site and the MSD
mutations.
The replication-deficient FV proviral construct pDL01 is based on the
FV vector pMH4 (
17), expressing the Gag-Pol and Env
proteins
from a chimeric cytomegalovirus (CMV) immediate-early
promoter-FV
promoter and an enhanced green fluorescent protein-
neo fusion (EGFP-Neo) from an internal spleen focus-forming virus
U3
promoter. pDL01 contains the EM02 mutation (
22) described
above and additional
BsmBI and
EcoRI restriction
sites upstream
and downstream of the Env open reading frame (ORF),
respectively,
to facilitate exchange of various portions of the FV Env
ORF.
The
BsmBI restriction site was introduced by a silent
mutation
so that the overlapping
pol ORF remained unaltered.
The individual
Env mutations were introduced into pDL01 as
NheI-
EcoRI fragments
from the pcHFVenv expression
constructs.
The replication-deficient pMH62 vector was described previously
(
26). It expresses the FV Gag-Pol proteins and contains
the
internal spleen focus-forming virus U3 promoter-directed EGFP
marker
gene expression
cassette.
Generation of recombinant FV supernatants and viral infectivity
assay.
Supernatants containing viruses with the different
recombinant envelopes were generated by transfection of 293T cells
(7) with vector pMH62 and the envelope expression constructs
essentially as described earlier (9, 21, 22). The
infectivity of the Env mutants was analyzed following transfection of
293T cells with pDL01 constructs and transduction of recipient HT1080
human fibrosarcoma cells with cell supernatant as described previously (17, 21) except that the amount of particle-associated Gag proteins was determined by Western blotting and quantitated by densitometry. The relative infectivity was then normalized for the Gag
content in the cell supernatant.
RIPA.
For the radioimmunoprecipitation assay (RIPA),
transiently transfected 293T cells were metabolically labeled with
[35S]methionine and [35S]cysteine for
approximately 20 h. The cells were lysed in RIPA buffer (20 mM
Tris [pH 7.4], 0.3 M NaCl, 1% Triton X-100, 0.1% [wt/vol] sodium
dodecyl sulfate [SDS]) containing protease inhibitors. Viral proteins
were precipitated as described earlier (9, 22) with rabbit
antisera directed against recombinant FV proteins and specific for Env
(22) and Gag (16). Particle-associated proteins
were detected after centrifugation through a 20% sucrose cushion as
described previously (9, 22).
Cell fusion assay.
The fusion activity of the different
envelope mutants was analyzed using a cell-to-cell fusion assay. 293T
cells were transiently transfected with the envelope expression
constructs and/or the FV vector pMH62. Empty expression vector
(pCDNA3.1+zeo) was used to adjust the amount of transfected DNA to 15 µg total. At 24 h following transfection, the cells were
detached from the tissue culture plates, mixed at a ratio of 1:1 with
HT1080 human fibrosarcoma target cells stably expressing a
beta-galactosidase marker protein with a nuclear localization signal
(NLS), and reseeded. Syncytia were allowed to form overnight.
Subsequently, cells were fixed and histochemically stained as described
previously (31). Fusion activity was quantified by counting
syncytia containing more than four nuclei in five independent fields of
view at a magnification of ×125. The sensitivity of the assay could be
increased by longer cocultivation of the Env-expressing cells and the
fusion partners and simultaneous induction of CMV-driven gene
expression by treatment with 10 mM sodium butyrate, resulting in about
10-fold-higher values for the weakly fusogenic mutants. The HT1080
NLS-lacZ cell line was generated by infection of HT1080
cells with an MuLV-based retroviral vector (SFG NLS-lacZ)
(30) and subsequent subcloning by limiting dilution.
Surface biotinylation assay.
Transiently transfected 293T
cells were metabolically labeled with [35S]methionine and
[35S]cysteine for approximately 20 h. At 36 h
after addition of the DNA, cell surface protein was labeled with
NHS-Biotin (Calbiochem) at 1 mg/ml in phosphate-buffered saline (PBS)
for 30 min. Subsequently, the biotinylation reaction was stopped by
adding PBS containing 100 mM glycine prior to cell lysis in RIPA
buffer. Lysates were precipitated with an FV-positive chimpanzee serum
as described earlier (9, 22), separated by
SDS-polyacrylamide gel electrophoresis and blotted on nitrocellulose
membranes (Hybond ECL; Amersham). Envelope protein expression at the
cell surface was analyzed by using streptavidin conjugated to
horseradish peroxidase (Pierce), followed by detection by enhanced
chemiluminescence (ECL) (Amersham). The chemoluminescent biotin signal
was allowed to fade overnight. Thereafter, the blot was exposed to
X-ray film, and total cellular envelope expression was detected by autoradiography.
 |
RESULTS |
Design of MSD mutations.
As found for primate lentiviruses,
one feature of the FV Env protein is an extremely long putative MSD, as
proposed previously (10, 33). Comparison of the amino acid
sequences of all known FV isolates reveals a clustering of several
evolutionarily conserved amino acids in the first half of this region
of the FV Env protein (Fig. 1A). Surprisingly, in the middle of the
putative MSD, a charged lysine residue followed by a proline residue,
known as a helix breaker, can be found. This is quite unusual for an
MSD, which is thought to adopt an
-helical conformation. To analyze the role of these two conserved residues in the function of FV Env
protein in the FV replication cycle, we generated several point
mutants. Furthermore, a truncation mutant terminating immediately after
P960 was generated, removing the C-terminal half of the putative MSD and the CyD. The individual mutants are depicted in Fig.
1B.
Influence of MSD mutants on FV particle release.
To analyze
the effect of the deletion mutation and the K959 and
P960 point mutations on FV particle release, 293T cells
were cotransfected with the individual Env expression plasmids and the
Gag-Pol-encoding FV vector pMH62. All mutants were expressed intracellularly at similar levels (Fig.
2A, lanes 1 to 10), and FV particle
egress was only reduced significantly by the P960A mutation
in EM22 and EM23 (Fig. 2B and C, lanes 2 and 3). All K959
single mutants released FV particles at levels similar to or higher
than those of the wild-type protein (Fig. 2B and C, lanes 1 and 4 to
7). Interestingly, the EM31 truncation mutant containing only the
N-terminal 15 amino acids of the putative MSD was still able to support
FV particle release (Fig. 2B and C, lane 8). The Env/Gag ratio of the
different particles was within a twofold range (Fig. 2D, lanes 1 to 9).

View larger version (86K):
[in this window]
[in a new window]
|
FIG. 2.
Expression analysis and support of FV particle release
by MSD mutants. 293T cells were cotransfected with pMH62 and the Env
expression constructs indicated below. (A) RIPA of metabolically
labeled cell lysates performed with rabbit sera specific for the FV Env
and Gag proteins. (B) Analysis of particle-associated FV proteins
purified by ultracentrifugation through a sucrose cushion. (C) Particle
release found with individual mutants relative to that with wild-type
Env was standardized for cellular expression levels. The
intensities of the cellular and supernatant Gag- and Env-specific bands
were quantitated by densitometry. The mean values ± standard errors for the individual mutants are expressed relative
to the EM02 construct, which was set at 1. The assays were performed
two to five times per mutant. (D) Mean ratio of viral
particle-associated Env to Gag proteins ± standard error as
determined by quantitation of Env and Gag bands. The assays were
performed two to five times per mutant. pMH62 was
cotransfected with pczHFVenv EM21 (lane 1), pczHFVenv EM22 (lane 2),
pczHFVenv EM23 (lane 3), pczHFVenv EM27 (lane 4), pczHFVenv EM28 (lane
5), pczHFVenv EM29 (lane 6), pczHFVenv EM30 (lane 7),
pczHFVenv EM31 (lane 8), pczHFVenv EM02 (lane 9), pCDNA3.1+zeo (lane
10), pcHFVenv EM33 (lane 11), pcHFVenv EM34 (lane 12), pcHFVenv EM35
(lane 13), pcHFVenv EM36 (lane 14), pcHFVenv EM37 (lane 15), pcHFVenv
EM38 (lane 16), pcHFVenv EM39 (lane 17), pcHFVenv EM40 (lane 18),
pcHFVenv EM20 (lane 19), pcHFVenv EM02 (lane 20), or pCDNA3.1+zeo (lane
21).
|
|
However, the first experiments with some of these mutants revealed that
altering the lysine residue dramatically increased
the fusion activity
of the FV Env protein (see below). In order
to examine the influence of
the individual MSD point mutations
on FV particle release independently
of cell lysis, occurring
as a result of the excessive syncytium
formation of Env-expressing
cells, we combined them with the FV Env
SU/TM cleavage mutant
EM20 (Fig.
1B). This mutant itself was
nonfusogenic (Fig.
3A)
and yielded
non-infectious particles (see Fig.
6) showing no morphologic
abnormalities in electron microscopy analysis (data not shown).
FV
particle release by the EM20 mutant was reduced about twofold
compared
with wild-type FV Env (Fig.
2B and C, lanes 19 and 20,
respectively).
Analysis of FV particle release by the combination
mutants revealed
major differences among the individual mutants
in supporting FV
particle egress (Fig.
2B and C, lanes 11 to 21).
In addition to the
P
960 mutants EM34 and EM35 (Fig.
2B and C,
lanes 12 and
13), the K
959 mutant EM33 (Fig.
2B and C, lane 11)
showed a
markedly reduced, mutants EM37, EM38, and EM39 (Fig.
2B and C, lanes 15 to 17) showed a marginally reduced, and EM36
(Fig.
2B and C, lane 14)
showed similar particle release compared
with the EM20 mutant itself
(Fig.
2B and C, lane 19). The truncation
mutant EM40 had significantly
higher FV particle release activity
than EM20 and slightly higher than
the cleavable wild-type protein
EM02 (Fig.
2B and C, lanes 18 to 20).
The Env/Gag ratio of all
mutants was within a twofold range compared
with the EM20 cleavage
mutant (Fig.
2D, lanes 11 to 20). Morphologic or
structural abnormalities
compared with wild-type particles could not be
observed by electron
microscopic analysis of several mutants (data not
shown).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Fusion activity of FV Env mutants. If not indicated
otherwise, 293T cells were transfected (A and B) with 15 µg of the
individual Env expression constructs alone, or (C) 7.5 µg of Env
expression plasmid and 7.5 µg of FV vector pMH62 expressing Gag-Pol
(+) or an empty control vector ( ) were cotransfected. The sensitivity
of the assay could be increased by extending the cocultivation period
from (A) 24 h to (B) 36 h with simultaneous sodium butyrate
treatment. The average number of syncytia counted per field of view is
given. The standard deviation for five fields counted per mutant is
indicated. wt, wild type.
|
|
Taken together, these data indicate that the C-terminal part of the
putative FV MSD is dispensable for FV particle egress.
In addition,
they imply a crucial role for the conserved P
960 in this
process and for K
959 when analyzed in a nonfusogenic
form.
K959 involved in control of FV Env fusion
activity.
As mentioned above, the first experiments involving some
of the point mutants showed a dramatic increase in syncytium formation in the transfected 293T cells. Therefore, we used a fusion assay to
analyze the fusogenic capacity of the individual mutants in further
detail. In this assay, 293T cells transfected with the envelope
expression constructs were mixed 24 h posttransfection with HT1080
fibrosarcoma cells constitutively expressing a nuclear
-galactosidase protein. After an additional 24-h incubation period, lacZ expression was analyzed by a histochemical staining
procedure, and syncytia were counted. In the analysis of fusion
activity, we included some additional mutants described previously
(Fig. 1B) (26). The different Env mutants examined could be
divided into four major groups (Fig. 3A). The group of mutants that
showed no syncytium formation at all consisted of the cleavage mutant EM20, the GPI-anchored HFE-3Pi, and the C-terminal truncation mutant
EM31 (Fig. 3A and B). Another group comprising the wild-type FV Env
protein (EM02), the conservative mutant EM27, the ER retrieval mutant
HFE-SSS, and the HFE-2 mutant lacking the CyD had low but clearly
detectable fusogenic activity (Fig. 3A and B). A third group included
mutants with medium fusogenic activity, being 10- to 15-fold higher
than found for the wild-type protein. Among those were the C-terminal
truncation mutant HFE-1 and the K959P960 double
mutant EM23 (Fig. 3A). Finally, the fourth group was made up of the
EM28 and EM29 mutants with altered charge as well as the EM21,
EM30, and EM22 mutants with hydrophobic amino acids in
place of K959 or P960, respectively, having a
20- to 40-fold-higher fusogenic activity than the wild type (Fig.
3A). The sensitivity of the assay could be increased by longer
cocultivation of the Env-expressing cells and the fusion partners,
resulting in about 10-fold-higher values for the weakly fusogenic
mutants (Fig. 3B). However, about 50 to 60 syncytia per view field was
the maximum number that was reliably countable. Even after prolonged
cultivation of cells transfected with nonfusogenic mutants, no syncytia
could be observed (Fig. 3B). An example of the microscopic view of
histochemically stained cell populations of one member of each group is
shown in Fig. 4. These data demonstrate
that the positively charged lysine residue at position 959 is involved
in regulation of FV Env fusion activity, with the charge at this
position playing an important role. Furthermore, they show that the
full-length putative MSD of FV Env is required for retaining fusion
activity, whereas the CyD is dispensable.

View larger version (172K):
[in this window]
[in a new window]
|
FIG. 4.
Sections of Env-expressing 293T cells cocultivated with
NLS-lacZ-expressing HT1080 cells after histochemical
-galactosidase staining. 293T cells were transfected with individual
Env expression constructs and subsequently cocultivated with HT1080
NLS-lacZ cells. The sections show fusion assays using (A)
the wild-type Env protein (EM02), (B) the truncation mutant HFE-1, (C)
the nonconservative mutant EM28 (K959E), and (D)
mock-transfected cells (pCDNA3.1+zeo).
|
|
Efficient cell fusion by wild-type FV Env requires coexpression of
capsids.
Syncytium formation is a hallmark of FV replication in
cell culture. Thus, we were surprised to find only low fusogenic
activity in our assay upon transfection of cells with the wild-type Env expression construct. We therefore examined the effect of Env-capsid interactions on Env fusogenic activity by cotransfecting 293T cells
with some of the Env-encoding plasmids together with the pMH62 FV
vector, expressing Gag-Pol, or with an empty vector backbone. As shown
in Fig. 3C, a dramatic increase in fusion activity was observed for the
low-fusogenic Env proteins (EM02, HFE-SSS, and EM27) when FV capsids
were coexpressed. No significant increase was observed for those
mutants (EM30) which were highly fusogenic in the preceding experiment.
However, since 50 to 60 syncytia per field of view was the
detection limit of the assay, we also analyzed a highly fusogenic
mutant (EM30) under conditions of reduced amounts of Env protein. In
this case, an increase in syncytium formation by coexpression of FV
capsids was detected (Fig. 3C). We conclude from these experiments that
the striking giant-cell formation upon FV replication in cell culture
requires the expression of both Env and capsids and that the role of
capsids could be overcome at least in part by mutating the conserved
lysine in the Env MSD.
Analysis of Env cell surface expression.
To analyze whether
the different fusogenic capacities of the mutated Env proteins depended
on their degree of surface expression or altered biological features,
we performed simultaneous surface biotinylation and metabolic
labeling assays on transfected 293T cells (Fig. 5A and
B). Relative cell surface expression of
the individual mutants was then normalized for total protein expression (Fig. 5C). Again, we used the individual MSD point mutants in combination with the EM20 SU/TM cleavage site mutant to avoid access of
Env proteins to biotinylation after the excessive syncytium formation
induced by some of the MSD point mutants. Control transfection of cells
with the pMH62 vector revealed the validity of the method, since the
Gag and Pol proteins expressed by this vector were readily precipitated, while no biotinylation of these proteins could be detected (Fig. 5A and B, lanes 9 and 20, respectively). The analysis revealed that the mutant with the conservative K959R
mutation displayed only a slightly higher cell surface expression (Fig. 5, lane 4), whereas all but one of the other point mutations affecting K959 or P960 (EM33 to EM36, EM37, and EM38) and
causing increased fusogenicity gave two- to eightfold-elevated cell
surface expression (Fig. 5, lanes 1 to 3, 5, and 6). The
K959L mutation in EM39 gave cell surface expression
slightly lower than that of wild-type FV Env (Fig. 5, lanes 7 and 8).
To determine whether the unique phenotype of this mutant Env was a
result of analysis in the uncleavable, nonfusogenic EM20 backbone, we
examined cell surface expression of the single mutant (EM30) and
compared it with that of the wild-type protein (EM02) as well as with
the K959D (EM29) mutant with similar fusion activity. Only
about fourfold more EM30 protein was biotinylated than wild-type
protein, whereas there was a significant difference compared with the
EM29 mutant, which had 15-fold more biotinylated protein than the wild
type, supporting the unique phenotype of the K959L mutation
in EM30 (Fig. 5A, lanes 11 to 13). Furthermore, analysis of the
previously described C-terminal truncation and point mutants revealed
that the nonfusogenic mutants HFE-3Pi and EM31 were expressed at four
to fivefold-higher levels than wild-type FV Env (Fig. 5A, lanes 16, 18, and 19), whereas the weakly fusogenic mutant HFE-2 showed a
fourfold-reduced expression level (Fig. 5A, lane 15). The other
mutants, HFE-1 and HFE-SSS, had cell surface expression levels only
slightly above that of wild-type FV Env (Fig. 5A, lanes 14, 17, and
19). Taken together, these results indicate that for most of the mutant
proteins, fusogenic activity deviating from that of wild-type Env
resulted from altered cell surface expression. However, the EM39
protein with the K959L mutation and one of the highest
fusion activities observed when present as a single mutation (EM30)
repeatedly showed cell surface expression levels slightly lower than
that of wild-type FV Env. Therefore, this mutation seems to activate
the fusion potential of the individual Env protein. Furthermore, these
data demonstrate that the C-terminal half of the putative MSD is
dispensable for stable membrane anchorage of the FV Env protein,
although it is required for retaining fusogenic capacity.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 5.
Env cell surface expression on transfected 293T cells.
293T cells were transfected with individual expression constructs and
metabolically labeled, and cell surface proteins were biotinylated. (A)
Chemoluminescent signals of biotinylated FV Env proteins after
incubation with streptavidin-horseradish peroxidase and detection by
ECL. (B) Autoradiogram of the radioimmunoprecipitated FV Env proteins
using a chimpanzee serum recognizing all major FV proteins including
Gag, Pol, and Env. (C) Mean relative cell surface expression ± standard error of individual FV Env mutants compared with the wild-type
protein (EM02), standardized for total Env expression. The assay was
performed two to three times per mutant. Radioactive signals and
chemoluminescent signals were quantitated by densitometric analysis of
the autoradiograms. The constructs tested were pcHFVenv EM33 (lane 1),
pcHFVenv EM34 (lane 2), pcHFVenv EM35 (lane 3), pcHFVenv EM36 (lane 4),
pcHFVenv EM37 (lane 5), pcHFVenv EM38 (lane 6), pcHFVenv EM39 (lane 7),
pcHFVenv EM20 (lane 8), pMH62 (lane 9), pCDNA3.1+zeo (lane 10),
pcHFVenv EM29 (lane 11), pcHFVenv EM30 (lane 12), pcHFVenv EM02 (lane
13), pcHFE-1 (lane 14), pcHFE-2 (lane 15), pcHFE-3Pi (lane 16),
pcHFE-SSS (lane 17), pcHFVenv EM31 (lane 18), pcHFVenv EM02 (lane 19),
pMH62 (lane 20), and pCDNA3.1+zeo (lane 21).
|
|
Infectivity of FV particles containing mutant Env proteins.
The infectivity of the released FV particles bearing mutated FV Env
MSDs was analyzed by an EGFP marker gene transfer assay as described in
Materials and Methods. 293T cells were transfected with the pDL01
constructs, and the cell-free virus titers were determined on HT1080
cells. The relative infectivity normalized for virus
particle-associated Gag proteins of the FV particles pseudotyped with
the individual mutants is shown in Fig.
6. The Env/Gag protein ratios of the
individual mutant particles were within a twofold range of that of the
wild-type control (data not shown). Supernatants containing particles
harboring the conservative K959R (EM27) mutant were as
infective as wild-type particles. The highly fusogenic
K959L (EM30) mutant had fourfold-decreased infectivity. All
other mutant particles showed 20- to 200-fold-decreased infectivities,
several around the detection limit of the assay. Taken together, these
data indicate that all but the conservative K959R and
K959L mutations severely impair the ability of the FV Env
protein to permit entry of viral particles into target cells.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 6.
Relative infectivity of mutant viral particles
normalized for virus-associated Gag proteins. 293T cells were
transfected with the pDL01 FV vector constructs harboring the
individual MSD mutants as indicated on the x axis. Transfer
of the EGFP-Neo marker gene to HT1080 target cells was analyzed as
described in Materials and Methods. The relative infectivities compared
with particles containing the wild-type (wt) FV Env (EM02) normalized
for the amount of viral particle-associated Gag proteins are given. The
standard deviation of two independent experiments is shown. The
detection limit of this assay is 0.5% of wild-type infectivity.
|
|
 |
DISCUSSION |
As we reported previously, the putative FV MSD of the TM subunit
plays an important role in FV particle egress (26). Using point mutations of two conserved residues within this domain, we
observed a crucial role for P960 in this process. In the
context of a nonfusogenic form of the FV Env protein having the SU/TM cleavage site inactivated, the negative effect of the P960
mutation was enhanced, and some K959 mutations also had a
negative effect. Since the cleavage site mutant itself exhibited
twofold-reduced particle release compared with the cleavable wild-type
Env protein, it cannot be excluded that conformational changes
introduced by the cleavage site mutation are the cause of the negative
effect observed for some of the K959 mutations on FV
particle release. For HIV-1 Env, for example, it has been observed that
SU/TM cleavage mutants are inefficiently incorporated into HIV-1
particles (6). On the other hand, it is also possible that
the supposedly normal particle release features of the nonconservative,
highly fusogenic, cleavable K959 mutations are at least
partially a result of the release of intracellular particles by massive
syncytium formation, thereby masking the release defect observed in the
noncleavable context.
The truncation mutation presented above, in the cleavable and
noncleavable contexts, shows that only the N-terminal 15 amino acids of
this domain are required for stable FV Env membrane anchorage and
support of FV particle release. This is somewhat reminiscent of HIV-1
Env, for which the C-terminal regions of the unusually long putative
MSD are similarly dispensable for stable cell surface expression
(25). In the putative MSD of MuLV Env, as few as eight amino
acids are sufficient to achieve membrane anchorage (27).
Similarly, as observed for the FV MSD truncation mutant EM31, analogous
HIV-1 and MuLV mutants were no longer fusogenic (25, 27),
implying that the MSD is involved in membrane fusion, but this function
is distinct from its role as a membrane anchor.
Upon expression of wild-type Env protein, we observed only weak
fusogenic activity. Point mutations involving the conserved positively
charged K959 and/or the adjacent P960 in the FV
Env MSD resulted in an increase in fusogenicity. For all but one of the
mutants, this increase is most probably mainly an effect of increased
cell surface expression. This may indicate that K959 is
part of a retention or retrieval signal negatively influencing the
export of FV Env. In contrast, the conservative K959R
mutant had fusion activity, cell surface expression, and FV particle release capacity comparable to those of the wild type, implying that
the positive charge at this position is crucial for proper FV Env
function. Interestingly, some of these point mutants showed significantly higher cell surface expression than a mutant in which the
previously described ER retrieval signal in the CyD was inactivated
(14), having a cell surface expression similar to that of
wild-type FV Env. Goepfert et al. (14) reported enhanced precursor cleavage for this SSS mutant, indicating faster intracellular transport of this mutant protein. We found similar results previously (26) (Fig. 4), as judged from analysis of precursor cleavage and endonuclease H resistance of the SSS precursor compared with the
wild-type protein. However, precursor cleavage is assumed to occur in
the distal Golgi, i.e., intracellularly before the Env protein appears
at the cell surface (8). Therefore, these results do not
necessarily exclude our observation of similar cell surface expression
for both proteins. Furthermore, we have recently identified additional
domains in the FV Env protein which, when deleted or inactivated,
result in dramatically increased intracellular transport and cell
surface expression even in the presence of an intact ER retrieval
signal in the CyD (unpublished observations). In our current view, the
ER retrieval signal influences intracellular distribution of the FV Env
protein but not cell surface expression. However, since we used a
different cell line (293T) than Goepfert et al. (14) (COS-1)
for analysis, a cellular effect for these differences cannot be excluded.
In the case of the HIV-1 Env, two arginine residues dispersed within
the MSD are vital for fusogenic activity (18, 25). However,
unlike the FV Env, changing the spacing or introducing a leucine
residue instead of the positively charged MSD residues abolished HIV-1
Env fusogenic activity without affecting cell surface expression
(18, 25). Changing the FV Env K959 to leucine resulted in drastic activation of the fusogenic activity of the individual Env proteins associated with cell surface expression at
wild-type levels. This demonstrated that this residue of the FV MSD is
directly involved in regulating FV fusion activity on the structural
level and not only by influencing its intracellular transport.
The coexpression of FV capsids together with wild-type Env protein
activated the fusion activity, as demonstrated by enhanced syncytium
formation in the fusion assay. We therefore conclude that not only is
FV Env required to export FV capsids, but also that FV capsid
expression is essential to relieve the intracellular retention of Env
protein. This retention could also be relieved by mutating the
conserved lysine in the Env MSD. We suggest that structural changes in
Env occur upon interaction with the capsid, which involves the
MSD. This implies specific interactions between FV capsids and Env,
which are currently under investigation.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge Ottmar Herchenröder for critical
comments on the manuscript.
This work was supported by the EU (BMH4-CT97-2010), Bayerische
Forschungsstiftung, and DFG (Li621/2-1). D.L. was supported by the
virology fellowship program of the BMBF, Germany.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Virologie, Universität Würzburg, Versbacher Str.
7, 97078 Würzburg, Germany. Phone: 49-931-201-3928. Fax:
49-931-201-3934. E-mail: lindemann{at}mail.uni-wuerzburg.de.
 |
REFERENCES |
| 1.
|
Baldwin, D. N., and M. L. Linial.
1998.
The roles of Pol and Env in the assembly pathway of human foamy virus.
J. Virol.
72:3658-3665[Abstract/Free Full Text].
|
| 2.
|
Brody, B. A.,
S. S. Rhee, and E. Hunter.
1994.
Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity.
J. Virol.
68:4620-4627[Abstract/Free Full Text].
|
| 3.
|
Bullough, P. A.,
F. M. Hughson,
J. J. Skehel, and D. C. Wiley.
1994.
Structure of influenza haemagglutinin at the pH of membrane fusion.
Nature
371:37-43[CrossRef][Medline].
|
| 4.
|
Carr, C. M.,
C. Chaudhry, and P. S. Kim.
1997.
Influenza hemagglutinin is spring-loaded by a metastable native conformation.
Proc. Natl. Acad. Sci. USA
94:14306-14313[Abstract/Free Full Text].
|
| 5.
|
Carr, C. M., and P. S. Kim.
1993.
A spring-loaded mechanism for the conformational change of influenza hemagglutinin.
Cell
73:823-832[CrossRef][Medline].
|
| 6.
|
Dubay, J. W.,
S. R. Dubay,
H. J. Shin, and E. Hunter.
1995.
Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation.
J. Virol.
69:4675-4682[Abstract].
|
| 7.
|
Du Bridge, R. B.,
P. Tang,
H. C. Hsia,
P. M. Leong,
J. H. Miller, and M. P. Calos.
1987.
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
Mol. Cell. Biol.
7:379-387[Abstract/Free Full Text].
|
| 8.
|
Einfeld, D.
1996.
Maturation and assembly of retroviral glycoproteins.
Curr. Top. Microbiol. Immunol.
214:133-176[Medline].
|
| 9.
|
Fischer, N.,
M. Heinkelein,
D. Lindemann,
J. Enssle,
C. Baum,
E. Werder,
H. Zentgraf,
J. G. Muller, and A. Rethwilm.
1998.
Foamy virus particle formation.
J. Virol.
72:1610-1615[Abstract/Free Full Text].
|
| 10.
|
Flügel, R. M.,
A. Rethwilm,
B. Maurer, and G. Darai.
1987.
Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes.
EMBO J.
6:2077-2084[Medline].
|
| 11.
|
Freed, E. O.,
D. J. Myers, and R. Risser.
1989.
Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
J. Virol.
63:4670-4675[Abstract/Free Full Text].
|
| 12.
|
Giron, M. L.,
H. de The, and A. Saib.
1998.
An evolutionarily conserved splice generates a secreted Env-Bet fusion protein during human foamy virus infection.
J. Virol.
72:4906-4910[Abstract/Free Full Text].
|
| 13.
|
Goepfert, P.,
K. Shaw,
G. Wang,
A. Bansal,
B. Edwards, and M. Mulligan.
1999.
An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes.
J. Virol.
73:7210-7217[Abstract/Free Full Text].
|
| 14.
|
Goepfert, P. A.,
K. L. Shaw,
G. D. Ritter, Jr., and M. J. Mulligan.
1997.
A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.
J. Virol.
71:778-784[Abstract].
|
| 15.
|
Goepfert, P. A.,
G. Wang, and M. J. Mulligan.
1995.
Identification of an ER retrieval signal in a retroviral glycoprotein.
Cell
82:543-544[CrossRef][Medline].
|
| 16.
|
Hahn, H.,
G. Baunach,
S. Bräutigam,
A. Mergia,
D. Neumann-Haefelin,
M. D. Daniel,
M. O. McClure, and A. Rethwilm.
1994.
Reactivity of primate sera to foamy virus Gag and Bet proteins.
J. Gen. Virol.
75:2635-2644[Abstract/Free Full Text].
|
| 17.
|
Heinkelein, M.,
M. Schmidt,
N. Fischer,
A. Moebes,
D. Lindemann,
J. Enssle, and A. Rethwilm.
1998.
Characterization of a cis-acting sequence in the pol region required to transfer human foamy virus vectors.
J. Virol.
72:6307-6314[Abstract/Free Full Text].
|
| 18.
|
Helseth, E.,
U. Olshevsky,
D. Gabuzda,
B. Ardman,
W. Haseltine, and J. Sodroski.
1990.
Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.
J. Virol.
64:6314-6318[Abstract/Free Full Text].
|
| 19.
|
Higuchi, R.
1990.
Recombinant PCR, p. 177-183.
In
M. A. Innis, D. H. Gelfand, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif.
|
| 20.
|
Hughson, F. M.
1997.
Enveloped viruses: a common mode of membrane fusion?
Curr. Biol.
7:R565-R569[CrossRef][Medline].
|
| 21.
|
Lindemann, D.,
M. Bock,
M. Schweizer, and A. Rethwilm.
1997.
Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
J. Virol.
71:4815-4820[Abstract].
|
| 22.
|
Lindemann, D., and A. Rethwilm.
1998.
Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing.
J. Virol.
72:4088-4094[Abstract/Free Full Text].
|
| 23.
|
Linial, M. L.
1999.
Foamy viruses are unconventional retroviruses.
J. Virol.
73:1747-1755[Free Full Text].
|
| 24.
|
Mulligan, M. J.,
G. V. Yamshchikov,
G. D. Ritter, Jr.,
F. Gao,
M. J. Jin,
C. D. Nail,
C. P. Spies,
B. H. Hahn, and R. W. Compans.
1992.
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.
J. Virol.
66:3971-3975[Abstract/Free Full Text].
|
| 25.
|
Owens, R. J.,
C. Burke, and J. K. Rose.
1994.
Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.
J. Virol.
68:570-574[Abstract/Free Full Text].
|
| 26.
|
Pietschmann, T.,
M. Heinkelein,
M. Heldmann,
H. Zentgraf,
A. Rethwilm, and D. Lindemann.
1999.
Foamy virus capsids require the cognate envelope protein for particle export.
J. Virol.
73:2613-2621[Abstract/Free Full Text].
|
| 27.
|
Ragheb, J. A., and W. F. Anderson.
1994.
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry.
J. Virol.
68:3207-3219[Abstract/Free Full Text].
|
| 28.
|
Rein, A.,
J. Mirro,
J. Gordon Haynes,
S. M. Ernst, and K. Nagashima.
1994.
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein.
J. Virol.
68:1773-1781[Abstract/Free Full Text].
|
| 29.
|
Ritter, G. D., Jr.,
M. J. Mulligan,
S. L. Lydy, and R. W. Compans.
1993.
Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
Virology
197:255-264[CrossRef][Medline].
|
| 30.
|
Riviere, I.,
K. Brose, and R. C. Mulligan.
1995.
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
Proc. Natl. Acad. Sci. USA
92:6733-6737[Abstract/Free Full Text].
|
| 31.
|
Schmidt, M., and A. Rethwilm.
1995.
Replicating foamy virus-based vectors directing high level expression of foreign genes.
Virology
210:167-178[CrossRef][Medline].
|
| 32.
|
Wang, G.,
D. Baldwin,
M. Linial, and M. Mulligan.
1999.
Endogenous virus of BHK-21 cells complicates electron microscopy studies of foamy virus maturation.
J. Virol.
73:8917[Free Full Text].
|
| 33.
|
Wang, G., and M. J. Mulligan.
1999.
Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses.
J. Gen. Virol.
80:245-254[Abstract].
|
| 34.
|
Weissenhorn, W.,
A. Dessen,
L. J. Calder,
S. C. Harrison,
J. J. Skehel, and D. C. Wiley.
1999.
Structural basis for membrane fusion by enveloped viruses.
Mol. Membr. Biol.
16:3-9[CrossRef][Medline].
|
Journal of Virology, May 2000, p. 4474-4482, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Li, Z., Blissard, G. W.
(2009). The Autographa californica Multicapsid Nucleopolyhedrovirus GP64 Protein: Analysis of Transmembrane Domain Length and Sequence Requirements. J. Virol.
83: 4447-4461
[Abstract]
[Full Text]
-
Stange, A., Luftenegger, D., Reh, J., Weissenhorn, W., Lindemann, D.
(2008). Subviral Particle Release Determinants of Prototype Foamy Virus. J. Virol.
82: 9858-9869
[Abstract]
[Full Text]
-
Lorin, A., Charloteaux, B., Fridmann-Sirkis, Y., Thomas, A., Shai, Y., Brasseur, R.
(2007). Mode of Membrane Interaction and Fusogenic Properties of a de Novo Transmembrane Model Peptide Depend on the Length of the Hydrophobic Core. J. Biol. Chem.
282: 18388-18396
[Abstract]
[Full Text]
-
Duda, A., Luftenegger, D., Pietschmann, T., Lindemann, D.
(2006). Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.. J. Virol.
80: 8158-8167
[Abstract]
[Full Text]
-
Stanke, N., Stange, A., Luftenegger, D., Zentgraf, H., Lindemann, D.
(2005). Ubiquitination of the Prototype Foamy Virus Envelope Glycoprotein Leader Peptide Regulates Subviral Particle Release. J. Virol.
79: 15074-15083
[Abstract]
[Full Text]
-
Cartellieri, M., Herchenroder, O., Rudolph, W., Heinkelein, M., Lindemann, D., Zentgraf, H., Rethwilm, A.
(2005). N-Terminal Gag Domain Required for Foamy Virus Particle Assembly and Export. J. Virol.
79: 12464-12476
[Abstract]
[Full Text]
-
Luftenegger, D., Picard-Maureau, M., Stanke, N., Rethwilm, A., Lindemann, D.
(2005). Analysis and Function of Prototype Foamy Virus Envelope N Glycosylation. J. Virol.
79: 7664-7672
[Abstract]
[Full Text]
-
Stange, A., Mannigel, I., Peters, K., Heinkelein, M., Stanke, N., Cartellieri, M., Gottlinger, H., Rethwilm, A., Zentgraf, H., Lindemann, D.
(2005). Characterization of Prototype Foamy Virus Gag Late Assembly Domain Motifs and Their Role in Particle Egress and Infectivity. J. Virol.
79: 5466-5476
[Abstract]
[Full Text]
-
Duda, A., Stange, A., Luftenegger, D., Stanke, N., Westphal, D., Pietschmann, T., Eastman, S. W., Linial, M. L., Rethwilm, A., Lindemann, D.
(2004). Prototype Foamy Virus Envelope Glycoprotein Leader Peptide Processing Is Mediated by a Furin-Like Cellular Protease, but Cleavage Is Not Essential for Viral Infectivity. J. Virol.
78: 13865-13870
[Abstract]
[Full Text]
-
Heinkelein, M., Rammling, M., Juretzek, T., Lindemann, D., Rethwilm, A.
(2003). Retrotransposition and Cell-to-Cell Transfer of Foamy Viruses. J. Virol.
77: 11855-11858
[Abstract]
[Full Text]
-
Verschoor, E. J., Langenhuijzen, S., van den Engel, S., Niphuis, H., Warren, K. S., Heeney, J. L.
(2003). Structural and Evolutionary Analysis of an Orangutan Foamy Virus. J. Virol.
77: 8584-8587
[Abstract]
[Full Text]
-
Picard-Maureau, M., Jarmy, G., Berg, A., Rethwilm, A., Lindemann, D.
(2003). Foamy Virus Envelope Glycoprotein-Mediated Entry Involves a pH-Dependent Fusion Process. J. Virol.
77: 4722-4730
[Abstract]
[Full Text]
-
Harman, A., Browne, H., Minson, T.
(2002). The Transmembrane Domain and Cytoplasmic Tail of Herpes Simplex Virus Type 1 Glycoprotein H Play a Role in Membrane Fusion. J. Virol.
76: 10708-10716
[Abstract]
[Full Text]
-
Lecellier, C.-H., Neves, M., Giron, M.-L., Tobaly-Tapiero, J., Saib, A.
(2002). Further Characterization of Equine Foamy Virus Reveals Unusual Features among the Foamy Viruses. J. Virol.
76: 7220-7227
[Abstract]
[Full Text]
-
Lindemann, D., Pietschmann, T., Picard-Maureau, M., Berg, A., Heinkelein, M., Thurow, J., Knaus, P., Zentgraf, H., Rethwilm, A.
(2001). A Particle-Associated Glycoprotein Signal Peptide Essential for Virus Maturation and Infectivity. J. Virol.
75: 5762-5771
[Abstract]
[Full Text]